Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Statins to Prevent Cancer Associated Blood Clots

for
Venous Thromboembolism, Cancer, Cardiovascular Events
Location: Boston MA, New Haven CT, Miami FL, Rochester MN,
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT07303816

Recruiting

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

for
Advanced Malignancies
Location: New York NY, Fairfax VA, Houston TX, Irving TX,
Sponsor: PharmaMar

Sex: All

Age: 18+

Code: NCT07644039

Phase 1, Phase 2, Recruiting

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

for
Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT07454499

Recruiting

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

for
Breast Cancer, Prostate Cancer
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT07441889

Phase 1, Phase 2, Recruiting

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

for
Obesity (Disorder), Breast Cancer
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18+

Code: NCT07257484

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

for
Refractory Acute Leukemia, Pediatric Relapsed
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT06397027

Phase 1, Recruiting

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New York NY, Fairfax VA, Toronto,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05765851

Phase 1, Recruiting

Magnetic Resonance Imaging in Radiotherapy for Breast Cancer

for
Breast Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05902507

Recruiting

CANnabinoids in Pediatric ONCology

for
Childhood Cancer, Cancer
Location: Halifax, Toronto, Vancouver
Sponsor: University of Manitoba

Sex: All

Age: 4 - 18

Code: NCT05754840

Phase 1, Phase 2, Recruiting

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

for
Cancer, Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06667427

Recruiting

Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program

for
Cancer, Cancer , Healthy
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07669753

Recruiting

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

for
Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07541365

Recruiting

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Location: Prince George
Sponsor: British Columbia Cancer Agency

Sex: Female

Age: 40+

Code: NCT06885671

Recruiting

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.

Sex: All

Age: 18+

Code: NCT05338073

Recruiting

Resilience-Building for Advance Care Planning

for
Advanced Cancer, End of Life
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT07428278

Recruiting

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

for
Advanced Solid Tumors With MAPK Pathway Mutations
Location: Detroit MI, Nashville TN, Houston TX
Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All

Age: 18+

Code: NCT05886920

Phase 1, Phase 2, Recruiting

GammaPod Registry and Quality of Life Nomogram

for
Breast Cancer Female
Location: Bel Air MD, Glen Burnie MD, Columbia MD, Dallas TX
Sponsor: University of Maryland, Baltimore

Sex: Female

Age: 18+

Code: NCT03562273

Recruiting

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

for
Advanced Malignant Tumors
Location: Quebec, Hackensack NJ, Germantown TN, Vancouver
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06764771

Phase 1, Recruiting

Pre-operative Magnetic Resonance Imaging (MRI) in Young Breast Cancer Patients

for
Breast Cancer, Magnetic Resonance Imaging, Preoperative MRI
Location: Hamilton
Sponsor: McMaster University

Sex: Female

Age: 0 - 50

Code: NCT00801476

Recruiting

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

for
Advanced Cancer
Location: Houston TX, Dallas TX, San Antonio TX
Sponsor: United Immunity, co., Ltd.

Sex: All

Age: 18+

Code: NCT07605962

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial